How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

17,256 results for

Anxiety Non-pharmacologic Management

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Diagnosis and management of epilepsy in adults

for a guideline should not be underestimated. In Scotland there are 54,000 people with active epilepsy affecting all ages, 1, 2 and there will be between 2,000 and 3,500 new diagnoses each year. 1 The low number of epilepsy specialists in previous decades means that many people with epilepsy across the UK have been diagnosed and treated by non-specialists in both primary and secondary care. Up to a quarter of patients referred for specialist management of apparent drug-resistant epilepsy do not have epilepsy (...) . It does not include patients with a non-epileptic attack disorder (see section 3.3.1). 1.2.2 TARGET USERS OF THE GUIDELINE This guideline will be of interest to all health professionals in primary and secondary care involved in the management of people with epilepsy, including general practitioners, practice nurses, epilepsy specialist nurses, general physicians, emergency department specialists, neurologists, obstetricians, clinical neuropsychologists and psychiatrists. It will also be of interest

2018 SIGN

142. Examining the Efficacy of the Anxiety Meter for Recognition and Management of Anxiety Signs in Autism Spectrum Disorder

of anxiety that can objectively measure and promote awareness of physiological arousal. To this end, the investigators have developed the Anxiety Meter, a device that measures arousal-related increases in heart rate using non-invasive wearable sensors and translates these to a visual display of the child's arousal level on a tablet computer. The investigators research questions are: Primary: Does the Anxiety Meter improve awareness and management of physiological arousal induced by anxiogenic stimuli (...) Examining the Efficacy of the Anxiety Meter for Recognition and Management of Anxiety Signs in Autism Spectrum Disorder Examining the Efficacy of the Anxiety Meter for Recognition and Management of Anxiety Signs in Autism Spectrum Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum

2014 Clinical Trials

143. End of life care for infants, children and young people with life-limiting conditions: planning and management

if they are not having treatment for it. 1.3.25 Think about non-pharmacological interventions for pain management, such as: changes that may help them to relax, for example: environmental adjustments (for example reducing noise) music physical contact such as touch, holding or massage local hot or cold applications to the site of pain comfort measures, such as sucrose for neonates. 1.3.26 When tailoring pain treatment for an individual child or young person, take into account their views and those of their parents (...) /terms-and- conditions#notice-of-rights). Page 22 of 44contributing to it think about non-pharmacological interventions, such as: calm speaking, reassurance, distraction, and physical contact such as holding and touch changes to the environment to make it more comfortable, calm and reassuring, to reduce noise and lighting, to maintain a comfortable room temperature, and to provide familiar objects and people and relaxing music religious and spiritual support if this is wanted and helpful think about

2016 National Institute for Health and Clinical Excellence - Clinical Guidelines

144. Multimorbidity: clinical assessment and management

-to-day life. Include in the discussion: the number and type of healthcare appointments a person has and where these take place the number and type of medicines a person is taking and how often any harms from medicines non-pharmacological treatments such as diets, exercise programmes and psychological treatments any effects of treatment on their mental health or wellbeing. 1.6.5 Be alert to the possibility of: depression and anxiety (consider identifying, assessing and managing these conditions (...) in the discussion. Agreeing the individualised management plan Agreeing the individualised management plan 1.6.17 After a discussion of disease and treatment burden and the person's, personal goals, values and priorities, develop and agree an individualised management plan with the person. Agree what will be recorded and what actions will be taken. These could include: starting, stopping or changing medicines and non-pharmacological treatments prioritising healthcare appointments anticipating possible changes

2016 National Institute for Health and Clinical Excellence - Clinical Guidelines

145. Motor neurone disease: assessment and management

and are not already using non-invasive ventilation. [new 2016] [new 2016] 1.12.4 Consider opioids [1] as an option to relieve symptoms of breathlessness. T ake into account the route of administration and acquisition cost of medicines. [new [new 2016] 2016] 1.12.5 Consider benzodiazepines [1] to manage breathlessness that is exacerbated by anxiety. T ake into account the route of administration and acquisition cost of medicines. [new 2016] [new 2016] 1.13 Cough effectiveness 1.13.1 Offer cough augmentation (...) Non-invasive ventilation 23 Context 34 Recommendations for research 36 1 Organisation of care 36 2 Cognitive assessment 36 3 Prognostic tools 36 4 Saliva 37 5 Nutrition 37 6 Augmentative and alternative communication 38 Update information 39 Amended recommendation wording (change to meaning) 39 Motor neurone disease: assessment and management (NG42) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 3 of 48This

2016 National Institute for Health and Clinical Excellence - Clinical Guidelines

146. Mental health problems in people with learning disabilities: prevention, assessment and management

interventions for children and young people with internalising disorders 34 3 Psychological interventions for depression and anxiety disorders in adults with mild to moderate learning disabilities 34 4 Pharmacological interventions for anxiety disorders in people with learning disabilities who have autism 35 5 Psychosocial interventions for people with more severe learning disabilities 36 6 The experiences of people with learning disabilities and mental health problems in services 37 Mental health problems (...) impairments. Mental health problems in people with learning disabilities: prevention, assessment and management (NG54) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 27 of 38Serious mental illness Serious mental illness Defined in this guideline as: severe and incapacitating depression or anxiety, psychosis, schizophrenia, bipolar disorder or schizoaffective disorder. Staff Staff Healthcare professionals and social care

2016 National Institute for Health and Clinical Excellence - Clinical Guidelines

147. Non-muscle-invasive Bladder Cancer

. Demand management in urine cytology: a single cytospin slide is sufficient. J Clin Pathol, 2000. 53: 718. 86. Nabi, G., et al. Suspicious urinary cytology with negative evaluation for malignancy in the diagnostic investigation of haematuria: how to follow up? J Clin Pathol, 2004. 57: 365. 87. Soria, F., et al. An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer. World J Urol, 36: 1981. 88. Lokeshwar, V.B., et al. Bladder tumor markers (...) and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients. J Urol, 2006. 176: 482. 238. Roumeguere, T., et al. Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropathy. Transpl Int, 2015. 28: 199. 239. Rodriguez, F., et al. [Practical guideline for the management of adverse events associated with BCG installations]. Arch Esp Urol, 2008. 61: 591. 240. Witjes

2019 European Association of Urology

148. Diagnosis and Treatment of Non-Neurogenic Overactive Bladder (OAB) in Adults: an AUA/SUFU Guideline

to the 2019 Guideline Amendment . Copyright © 2019 American Urological Association Education and Research, Inc.® 2 Overactive Bladder therapy to all patients with OAB. Standard (Evidence Strength Grade B) 7. Behavioral therapies may be combined with pharmacologic management. Recommendation (Evidence Strength Grade C) Second-Line Treatments: Pharmacologic Management 8. Clinicians should offer oral anti-muscarinics or oral ß3-adrenoceptor agonists as second-line therapy. Standard (Evidence Strength Grade B (...) to comply with pharmacologic management, third-line therapies of neuromodulation (PTNS, SNS) and intradetrusor onabotulinumtoxinA may be considered. Patients who are felt to be reasonable candidates for third-line therapies who have been treated by nonspecialists will require referral to a specialist. In some cases the specialist may opt to obtain further information with voiding diaries or symptom questionnaires, or may do further testing such as urodynamics to rule out other bladder pathologies

2019 American Urological Association

149. Osimertinib (Tagrisso) - non-small cell lung cancer (NSCLC)

agent TKIs should be offered to patients with advanced NSCLC who have a sensitising EGFR mutation. Adding combination systemic anticancer therapy to a TKI confers no benefit and should not be used. 9 In March 2019 the National Institute for Health and Care Excellence (NICE) issued clinical guideline number 122, Lung Cancer: Diagnosis and Management. For guidance on initial treatment for stage IIIB and IV non-squamous NSCLC in people EGFR-TK mutation this references the NICE technology appraisal (...) Network (SIGN). Publication number 137, Management of Lung Cancer, February 2014. 10. National Institute for Health and Care Excellence (NICE). Clinical guideline number 122, Lung Cancer: Diagnosis and Management, March 2019. 11. National Institute for Health and Care Excellence (NICE).Technology appraisal number 310, Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer, 23 April 2014. 12. National Institute for Health

2019 Scottish Medicines Consortium

150. Diagnosis and Treatment of Non-Neurogenic Overactive Bladder (OAB) in Adults

Managers' Network (PMN) Patient Safety and Quality of Care Accreditations and Reporting Patient Education Diagnosis and Treatment of Non-Neurogenic Overactive Bladder (OAB) in Adults (2019) AUA/SUFU Guideline: Published 2012; Amended 2014, 2019 The clinical guideline on Diagnosis and Treatment of Non-Neurogenic Overactive Bladder (OAB) in Adults discusses patient presentation, diagnosis, treatment, and follow-up of patients based on the currently available data. [pdf] [pdf] Panel Members E. Ann Gormley (...) : Behavioral Therapies 6. Clinicians should offer behavioral therapies (e.g., bladder training, bladder control strategies, pelvic floor muscle training, fluid management) as first line therapy to all patients with OAB. Standard (Evidence Strength Grade B) 7. Behavioral therapies may be combined with pharmacologic management. Recommendation (Evidence Strength Grade C) Second-Line Treatments: Pharmacologic Management 8. Clinicians should offer oral anti-muscarinics or oral β 3 -adrenoceptor agonists

2019 American Urological Association

151. Cognitive-Behavioural Therapy for Anxiety and Depression in Patients With Chronic Obstructive Pulmonary Disease

is the clinical effectiveness of cognitive-behavioural therapy (CBT) for patients with chronic obstructive pulmonary disease (COPD) and coexisting anxiety or depression? Research Methods Literature Search Search Strategy A literature search was performed on April 25, 2014, using Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, and EBM Reviews, for studies published from January 1, 2008, to April 15, 2014. (Appendix 1 provides details of the search strategy.) Abstracts were reviewed (...) ? control groups of usual care, education, inactive controls, or active controls Exclusion Criteria ? randomized controlled trials (RCT), observational studies, case reports, editorials, conference abstracts ? studies in other populations (e.g., elderly, general population) ? studies of the effectiveness of pharmacologic or other treatments, or comparative effectiveness of treatments Outcomes of Interest ? change in symptoms of anxiety and/or depression ? quality of life Expert Panel In November 2013

2015 Health Quality Ontario

152. Evaluation of anxiety and depression in mothers of children with asthma (PubMed)

Evaluation of anxiety and depression in mothers of children with asthma Asthma is the most common chronic disease in childhood. Parents have an important role in managing asthma in children. Studies have shown a higher degree of depression and anxiety and lower family performance in mothers of asthmatic children in comparison with the control group.The aim of this study was to evaluate the parenting styles and also depression, anxiety and stress parameters in mothers of children (...) with asthma.This case-control study was performed on 45 mothers of 3 to 15 years old asthmatic children in the allergy clinic of Mashhad University of Medical Sciences, Mashhad, Iran, during the years of 2014 to 2016. The control group was 45 mothers of non-asthmatic children who were matched for the age of their children with the case group in the same population. The parenting styles, as well as depression and anxiety of mothers were evaluated using parenting scales, and the depression-anxiety-stress scales

Full Text available with Trip Pro

2017 Electronic physician

153. Adjustment to Cancer: Anxiety and Distress (PDQ®): Health Professional Version

Management. Version 1.2019. Plymouth Meeting, Pa: National Comprehensive Cancer Network, 2019. . Last accessed March 4, 2019. Lauver D, Ho CH: Explaining delay in care seeking for breast cancer symptoms. J Appl Soc Psychol 23 (21): 1806-25, 1993. MacFarlane ME, Sony SD: Women, breast lump discovery, and associated stress. Health Care Women Int 13 (1): 23-32, 1992 Jan-Mar. [ ] Gram IT, Slenker SE: Cancer anxiety and attitudes toward mammography among screening attenders, nonattenders, and women never (...) Symptom Manage 10 (2): 120-8, 1995. [ ] Ferrell-Torry AT, Glick OJ: The use of therapeutic massage as a nursing intervention to modify anxiety and the perception of cancer pain. Cancer Nurs 16 (2): 93-101, 1993. [ ] Davis-Ali SH, Chesler MA, Chesney BK: Recognizing cancer as a family disease: worries and support reported by patients and spouses. Soc Work Health Care 19 (2): 45-65, 1993. [ ] Dahlquist LM, Czyzewski DI, Copeland KG, et al.: Parents of children newly diagnosed with cancer: anxiety

2018 PDQ - NCI's Comprehensive Cancer Database

154. Mindfulness Interventions for the Treatment of Post-Traumatic Stress Disorder, Generalized Anxiety Disorder, Depression, and Substance Use Disorders

and depression and included three studies using mindfulness-based cognitive therapy, three studies using mindfulness-based stress reduction and three studies using acceptance-based behavior therapy. Hayes-Skelton et al. 29 compared acceptance-based behavior therapy with applied relaxation in adult patients with principal diagnosis of GAD. Anxiety and QoL were assessed in this RCT. Hoge et al. 30 compared mindfulness-based stress reduction to stress management education in adult patients with current primary (...) GAD. The impact of a mindfulness intervention on anxiety was assessed in this trial. Substance use disorders One systematic review, 17 and one RCT 28 assessing mindfulness interventions in patients with substance use disorder were identified. The systematic review by Chiesa and Serretti 17 was conducted in Italy and included 24 studies (14 RCTs and ten non-RCTs). Twelve studies focused on alcohol and/or heterogeneous substance use, four on cigarette smoking, three on Mindfulness for PTSD, GAD

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

155. Yoga for the Treatment of Post-Traumatic Stress Disorder, Generalized Anxiety Disorder, Depression, and Substance Abuse

1):s54-s64. 36. VA/DoD clinical practice guideline for management of post-traumatic stress [Internet]. Washington (DC): Department of Veterans Affairs (US); 2010. [cited 2015 Jun 12]. Available from: http://www.healthquality.va.gov/guidelines/MH/ptsd/cpgPTSDFULL201011612c.pdf 37. Baldwin DS, Anderson IM, Nutt DJ, Allgulander C, Bandelow B, den Boer JA, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder (...) : a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014 May;28(5):403- 39. 38. Non-pharmaceutical management of depression in adults: a national clinical guideline [Internet]. Edinburgh: Scottish Intercollegiate Guidelines Network; 2010 Jan. [cited 2015 Jun 12]. Available from: http://www.sign.ac.uk/pdf/sign114.pdf 39. Newham JJ, Wittkowski A, Hurley J, Aplin JD, Westwood M. Effects of antenatal yoga on maternal anxiety and depression: a randomized

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

156. Engagement and outcomes for a computerised cognitive-behavioural therapy intervention for anxiety and depression in African Americans. (PubMed)

aged 18-75, enrolled in a randomised clinical trial of collaborative care embedded with an online treatment for depression and anxiety.Patients with moderate levels of mood and/or anxiety symptoms (PHQ-9 or GAD-7≥10) were randomised to receive either care-manager-guided access to the proven-effective Beating the Blues® CCBT programme or usual care from their primary care doctor.Compared with White participants, African Americans were less likely to start the CCBT programme (P=0.01), and those who (...) Engagement and outcomes for a computerised cognitive-behavioural therapy intervention for anxiety and depression in African Americans. Computerised cognitive-behavioural therapy (CCBT) helps improve mental health outcomes in White populations. However, no studies have examined whether CCBT is acceptable and beneficial for African Americans.We studied differences in CCBT use and self-reported change in depression and anxiety symptoms among 91 African Americans and 499 White primary care patients

Full Text available with Trip Pro

2017 BJPsych open Controlled trial quality: uncertain

157. Surgical Management of Miscarriage and Removal of Persistent Placental or Fetal Remains (Consent Advice No. 10 ? Joint with AEPU)

analogues l expectant management. Expectant, medical and surgical treatment of early pregnancy loss have similar rates of complications, such as duration and severity of pain, incidence of pelvic infection and the level of anxiety experienced. 6,23 A recent Cochrane review 24 found no difference in the success between misoprostol and waiting for spontaneous miscarriage (expectant care), or between misoprostol and surgery. The overall success rate of treatment (misoprostol and surgery) was over 80 (...) Surgical Management of Miscarriage and Removal of Persistent Placental or Fetal Remains (Consent Advice No. 10 ? Joint with AEPU) Surgical Management of Miscarriage and Removal of Persistent Placental or Fetal Remains Consent Advice No. 10 (Joint with AEPU) January 2018Surgical Management of Miscarriage and Removal of Persistent Placental or Fetal Remains This is the second edition of this guidance, which was published in 2010 under the title Surgical Evacuation of the Uterus for Early

2018 Royal College of Obstetricians and Gynaecologists

158. Opioid Use Disorder - Diagnosis and Management in Primary Care

disease that benefits from a compassionate, patient-centred and non-judgemental approach. There are multiple, individual paths to treatment, stabilization, and recovery. Lack of access to counselling should NOT be a barrier to starting opioid agonist treatment. If available, and aligned with the patient’s treatment goals, offer referrals to psychosocial treatment interventions and supports in conjunction with pharmacological treatment. If you are new to buprenorphine/naloxone prescribing, consider (...) are you sleeping?” “How is your mood/anxiety?” “How are things at home?” Relapse is common and should not be seen as a failing. OUD is a chronic, relapsing condition. As in other chronic diseases, treatment strategies should be adjusted. Patients should not be asked to leave treatment if they relapse. It is critical to provide patients with non-judgemental support and encouragement in achieving their goals. PharmaNet should be checked to corroborate treatment adherence or missed doses. Generally

2018 Clinical Practice Guidelines and Protocols in British Columbia

159. Physiologic Basis of Pain in Labour and Delivery: An Evidence-Based Approach to its Management

health care professionals have a good understanding of pain in childbirth including its physiological and psychological management whether or not a person in labour also chooses pharmacological relief (III). 2. A growing body of scientific literature supports the use of nonpharmacological approaches to pain management during childbirth due to their numerous benefits for the mother and child, including a reduction in the need for obstetrical interventions, labour augmentation, or Caesarean section (l (...) management during childbirth, reduces stress, fear, and anxiety, which in turn decreases the frequency of obstetrical interventions (I). 8. Natural oxytocin is not only important for uterine contractions; it enhances a sense of calmness and reduces pain. Because synthetic oxytocin does not cross the blood-brain barrier in a significant manner, the analgesic and psychological effects on the mother of calmness and well-being are lost (II). 9. Elevated endorphins in labour help reduce maternal stress

2018 Society of Obstetricians and Gynaecologists of Canada

160. Management of Stroke in Neonates and Children

with AIS when implemented within discrete time windows. The availability of recanalization therapy has therefore dramatically changed the time frame for urgent diagnosis and management of stroke. , Whether and how to apply these therapies in childhood remain controversial. Implications of Thrombus Composition Thrombus composition (erythrocytes, fibrin, platelets, and leukocytes) is integral in determining susceptibility to mechanical and pharmacological disruption and recanalization. Thrombus (...) Management of Stroke in Neonates and Children Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association | Stroke Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 February 2019 February 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article , MD, MS, FAHA, Co

Full Text available with Trip Pro

2019 American Heart Association

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>